Redeye: Orexo - Zubsolv US Sales Data and a DTx Comment
Redeye brings fresh data about the sales of Zubsolv in the US and a comment on the reimbursement of digital therapies. Read more and download the Research Update: https://bit.ly/3deJTIU Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/